Background: COVID-19 pandemic is rapidly spreading all over the world, creating the risk for an healthcare collapse. While acute care and intensive care units are the main pillars of the early response to the disease, rehabilitative medicine should play an important part in allowing COVID-19 survivors to reduce disability and optimize the function of acute hospital setting.
Aim: To share the experience and the international perspective of different rehabilitation centers, treating COVID-19 survivors.
Design: Not applicable.
Population: COVID-19 survivors.
Methods: A group of Physical Medicine & Rehabilitation specialists from eleven different countries in Europe and North America have shared their clinical experience in dealing with COVID-19 survivors and how they have managed the re-organization of rehabilitation services.
Results: In our experience the most important sequelae of severe and critical forms of COVID-19 are: 1) respiratory; 2) cognitive, central and peipheral nervous system; 3) deconditioning; 4) critical illness related myopathy and neuropathy; 5) dysphagia; 6) joint stiffness and pain; 7) psychiatric.
Conclusions: We analyze all these consequences and propose some practical treatment options, based on current evidence and clinical experience, as well as several suggestions for management of rehabilitation services and patients with suspected or confirmed infection by SARS-CoV-2.
Clinical rehabilitation impact: COVID-19 survivors have some specific rehabilitation needs. Experience from other centers may help colleagues in organizing their services and providing better care to their patients.
Considerations for Postacute Rehabilitation for Survivors of COVID-19.JMIR Public Health Surveill. 2020 May 8;6(2):e19462. doi: 10.2196/19462. JMIR Public Health Surveill. 2020. PMID: 32369030 Free PMC article.
Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-converting Enzyme 2 as a Potential Drug Target - A Perspective.Endocr Metab Immune Disord Drug Targets. 2020 Apr 27. doi: 10.2174/1871530320666200427112902. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 32338224
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.Oncologist. 2020 Apr 3. doi: 10.1634/theoncologist.2020-0213. Online ahead of print. Oncologist. 2020. PMID: 32243668
Stroke care during the Covid-19 pandemic: Experience from three large European countries.Eur J Neurol. 2020 Jun 3. doi: 10.1111/ene.14375. Online ahead of print. Eur J Neurol. 2020. PMID: 32492764 Review.
Osteoarthritis. The role of physical and rehabilitation medicine physicians. The European perspective based on the best evidence. A paper by the UEMS-PRM Section Professional Practice Committee.Eur J Phys Rehabil Med. 2013 Aug;49(4):579-93. Eur J Phys Rehabil Med. 2013. PMID: 24084416 Review.